---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-103804"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:14:34.143135+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Globus Medical and NuVasive disclose supplemental proxy info to settle merger lawsuits

## Summary
- Five shareholder complaints filed in March-April 2023 in NY, DE, and Colorado courts alleging incomplete/misleading proxy statement for the merger.
- NuVasive and Globus Medical deny merit but are making supplemental disclosures to avoid risk of delaying the merger.
- Supplemental disclosures add details: no acquisition proposals received during Window Shop Period (ended March 10, 2023).
- Supplemental disclosures also provide additional details on Goldman Sachs and BofA financial analyses, including net debt adjustments and discount rate ranges.
- Defendants are not admitting legal necessity or materiality of the supplemental disclosures.

## SEC filing metadata
- accession: 0001193125-23-103804
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000119312523103804/0001193125-23-103804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000119312523103804/d476164d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-103804
- JSON: https://secwatch.observer/filing/0001193125-23-103804.json
- Plain text: https://secwatch.observer/filing/0001193125-23-103804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.